
  
    
      
        
        Francis_NNP Hamilton_NNP ,_, the_DT Briton_NN who_WP first_RB described_VBD zebrafish_NN (_(
        Danio_NNP rerio_NN )_) in_IN 1822_CD ,_, would_MD be_VB astounded_JJ to_TO see_VB the_DT scientific_JJ
        attention_NN now_RB afforded_VBN to_TO this_DT two-inch-long_JJ native_NN of_IN Indian_JJ rivers_NNS ._. A_DT fish_NN with_IN no_DT
        economic_JJ worth_NN was_VBD how_WRB he_PRP described_VBD this_DT little_JJ creature_NN ._. Yet_RB recently_RB ,_, the_DT European_NNP Union_NNP
        awarded_VBD 12_CD million_CD Euros_NNP to_TO the_DT ZF-MODELS_NNP research_NN consortium_NN to_TO study_VB zebrafish_NN models_NNS for_IN
        human_JJ development_NN and_CC disease_NN ._. When_WRB and_CC why_WRB did_VBD zebrafish_NN swim_VBP from_IN home_NN aquaria_NN into_IN
        research_NN labs_NNS ,_, and_CC what_WP can_MD we_PRP learn_VB about_IN our_PRP$ biology_NN from_IN this_DT surprising_JJ source_NN ?_.
      
      
        The_DT Early_JJ Days_NNS
        It_PRP was_VBD the_DT late_JJ 1960_CD s_VBZ when_WRB phage_NN geneticist_NN George_NNP Streisinger_NNP began_VBD to_TO look_VB for_IN a_DT model_NN
        system_NN in_IN which_WDT to_TO study_VB the_DT genetic_JJ basis_NN of_IN vertebrate_NN neural_NN development_NN ._. His_PRP$ passion_NN
        for_IN tropical_JJ fish_NN led_VBD him_PRP to_TO the_DT humble_JJ zebrafish_NN ._. He_PRP was_VBD a_DT ‘ visionary_JJ’ ,_, remembers_VBZ
        neurobiologist_NN Judith_NNP Eisen_NNP (_( University_NNP of_IN Oregon_NNP ,_, Eugene_NNP ,_, Oregon_NNP ,_, United_NNP States_NNPS )_) ,_, ‘ who_WP
        laid_VBD the_DT groundwork_NN for_IN the_DT use_NN of_IN zebrafish_NN as_IN a_DT developmental_NN model_NN’ ._.
        Eisen_NNP ,_, who_WP now_RB heads_VBZ her_PRP$ own_JJ research_NN group_NN ,_, went_VBD to_TO Oregon_NNP in_IN 1983_CD to_TO work_VB on_IN 
        Xenopus_NNP neural_NN development_NN but_CC soon_RB became_VBD attracted_VBN to_TO
        zebrafish_NN as_IN a_DT model_NN organism_NN ._. By_IN the_DT early_JJ 1980_CD s_VBZ ,_, she_PRP explains_VBZ ,_, Streisinger_NNP had_VBD worked_VBN out_IN
        many_JJ of_IN the_DT genetic_JJ tricks_NNS needed_VBN to_TO tackle_VB zebrafish_NN development_NN ._. What_WP 's_VBZ more_JJR ,_, the_DT fish_NN
        had_VBD ‘ wonderful_JJ embryology_NN’ ._. The_DT embryo_NN ,_, which_WDT develops_VBZ outside_IN its_PRP$ mother_NN ,_, is_VBZ transparent_JJ ._.
        ‘ You_PRP can_MD see_VB different_JJ cell_NN types_NNS ,_, watch_VB individual_JJ cells_NNS develop_VBP ,_, do_VBP transplantation_NN
        experiments_NNS’ ,_, Eisen_NNP enthuses_NNS ,_, ‘ and_CC development_NN is_VBZ quick_JJ but_CC not_RB too_RB quick_JJ’ ._. Being_VBG able_JJ to_TO
        watch_VB individual_JJ neurons_NNS developing_VBG in_IN real_JJ time_NN opened_VBD up_RB whole_JJ new_JJ avenues_NNS of_IN research_NN
        for_IN Eisen_NNP and_CC other_JJ neurobiologists_NNS ._.
      
      
        Fast_NNP Forward_NNP to_TO the_DT Big_NNP Screen_NNP
        The_DT properties_NNS of_IN zebrafish_NN that_WDT attracted_VBD Eisen_NNP soon_RB attracted_VBD people_NNS interested_VBN in_IN
        other_JJ aspects_NNS of_IN vertebrate_NN development_NN to_TO the_DT stripy_NN tiddler_NN (_( Figure_NN 1_LS )_) ._. As_IN Eisen_NNP
        comments_NNS :_: ‘ No_DT other_JJ developmental_NN model_NN has_VBZ risen_VBN to_TO prominence_NN so_RB quickly_RB’ ._. These_DT days_NNS
        more_JJR than_IN 3_CD ,_, 000_CD researchers_NNS are_VBP listed_VBN on_IN ZFIN_NNP ,_, a_DT United_NNP States–based_NNP information_NN resource_NN
        for_IN the_DT zebrafish_NN research_NN community_NN ._.
        The_DT speedy_JJ expansion_NN was_VBD driven_VBN in_IN great_JJ part_NN by_IN two_CD genetic_JJ screens_NNS initiated_VBN in_IN
        1992_CD –_NN 1993_CD by_IN Christiane_NNP Nüsslein-_NNP Volhard_NNP in_IN Tübingen_NNP ,_, Germany_NNP ,_, and_CC Wolfgang_NNP Driever_NNP and_CC
        Mark_NNP Fishman_NNP in_IN Boston_NNP ,_, Massachusetts_NNP ._. The_DT aim_NN of_IN both_DT screens_NNS was_VBD to_TO identify_VB genes_NNS with_IN
        unique_JJ and_CC essential_JJ functions_NNS in_IN zebrafish_NN development_NN ,_, and_CC in_IN 1996_CD an_DT issue_NN of_IN the_DT
        journal_NN 
        Development_NNP was_VBD dedicated_VBN to_TO the_DT mutants_NNS that_WDT had_VBD been_VBN isolated_VBN and_CC
        characterised_JJ ._. These_DT screens_NNS ,_, says_VBZ Ralf_NNP Dahm_NNP (_( Max_NNP Planck_NNP Institute_NNP for_IN Developmental_NNP
        Biology_NNP ,_, Tübingen_NNP ,_, Germany_NNP )_) ,_, project_NN manager_NN of_IN the_DT ZF-MODELS_NNP consortium_NN ,_, ‘ were_VBD the_DT first_JJ
        major_JJ zebrafish_NN projects_NNS ,_, and_CC they_PRP showed_VBD that_DT zebrafish_NN was_VBD a_DT model_NN organism_NN to_TO be_VB
        reckoned_VBN with_IN’ ._.
        ‘ That_DT was_VBD a_DT fantastic_JJ time_NN’ ,_, says_VBZ Derek_NNP Stemple_NNP ,_, then_RB a_DT postdoc_NN with_IN Driever_NNP but_CC now_RB a_DT
        group_NN leader_NN at_IN the_DT Wellcome_NNP Trust_NNP Sanger_NNP Institute_NNP (_( Cambridge_NNP ,_, United_NNP Kingdom_NNP )_) and_CC a_DT
        ZF-MODELS_NNP participant_NN ._. ‘ From_IN Wolfgang_NNP 's_POS lab_NN ,_, I_PRP was_VBD able_JJ to_TO take_VB the_DT mutations_NNS that_WDT affected_VBD
        notochord_NN development_NN ,_, and_CC have_VBP been_VBN studying_VBG them_PRP ever_RB since_IN’ ._. The_DT notochord_NN is_VBZ an_DT
        embryonic_JJ structure_NN that_IN forms_VBZ the_DT primitive_JJ axial_NN skeleton_NN of_IN the_DT developing_VBG embryo_NN ,_, and_CC
        because_IN mutations_NNS affecting_VBG notochord_NN development_NN result_NN in_IN shortened_VBN embryos_NNS ,_, seven_CD of_IN the_DT
        affected_VBN genes_NNS have_VBP been_VBN named_VBN after_IN the_DT dwarves_NNS in_IN Snow_NNP White—zebrafish_NNP ,_, like_IN some_DT other_JJ
        developmental_NN models_NNS ,_, have_VBP many_JJ imaginatively_RB named_VBN mutants_NNS ._. Stemple_NNP now_RB knows_VBZ the_DT identity_NN
        of_IN six_CD of_IN these_DT mutated_VBN genes_NNS ,_, all_DT of_IN which_WDT lead_VBP to_TO disruption_NN of_IN basement_NN membrane_NN around_IN
        the_DT notochord_NN ._.
        Many_JJ mutants_NNS from_IN those_DT first_JJ two_CD screens_NNS are_VBP still_RB used_VBN by_IN developmental_NN biologists_NNS ,_,
        but_CC another_DT set_NN of_IN mutants_NNS has_VBZ recently_RB been_VBN isolated_VBN by_IN Nancy_NNP Hopkins_NNP ,_, Amgen_NNP Professor_NNP of_IN
        Biology_NNP at_IN the_DT Massachusetts_NNP Institute_NNP of_IN Technology_NNP (_( Cambridge_NNP ,_, Massachusetts_NNP ,_, United_NNP
        States_NNPS )_) ._. About_IN ten_CD years_NNS ago_RB ,_, Hopkins_NNP started_VBD to_TO develop_VB insertional_NN mutagenesis_NNS in_IN
        zebrafish_NN (_( Figure_NN 2_LS )_) ._. In_IN this_DT approach_NN ,_, mutations_NNS are_VBP caused_VBN by_IN the_DT random_JJ insertion_NN of_IN
        viral_JJ DNA_NNP throughout_IN the_DT fish_NN genome_NN ._. The_DT inserted_VBN DNA_NNP acts_NNS as_IN a_DT tag_NN ,_, making_VBG cloning_VBG of_IN
        mutated_VBN genes_NNS very_RB straightforward_JJ ,_, although_IN the_DT efficiency_NN of_IN the_DT initial_JJ insertional_NN
        mutagenesis_NNS is_VBZ much_RB lower_JJR than_IN that_DT of_IN the_DT chemical_NN mutagenesis_NNS used_VBN in_IN the_DT 1992_CD –_NN 1993_CD
        screens_NNS ._. Hopkins_NNP has_VBZ isolated_VBN 550_CD mutants_NNS in_IN her_PRP$ screen_NN ,_, representing_VBG around_IN 400_CD different_JJ
        genes_NNS ,_, and_CC has_VBZ cloned_VBN more_JJR than_IN 300_CD of_IN these_DT genes_NNS to_TO date_NN ._. Some_DT of_IN the_DT fruits_NNS of_IN this_DT
        project_NN are_VBP published_VBN in_IN this_DT issue_NN of_IN PLoS_NNP Biology_NNP ._. Hopkins_NNP 's_POS group_NN is_VBZ now_RB collaborating_VBG
        with_IN 25_CD external_JJ laboratories_NNS on_IN the_DT annotation_NN of_IN the_DT mutant_JJ collection_NN with_IN funding_NN from_IN
        the_DT National_NNP Center_NNP for_IN Research_NNP Resources_NNPS ,_, part_NN of_IN the_DT United_NNP States_NNPS National_NNP Institutes_NNPS
        of_IN Health_NNP ._.
        The_DT Tübingen_NNP researchers_NNS did_VBD another_DT chemical_NN mutagenesis_NNS screen_NN between_IN 2000_CD and_CC 2001_CD ,_,
        and_CC are_VBP now_RB starting_VBG a_DT third_JJ screen_NN of_IN 6_CD ,_, 000_CD genomes_NNS as_IN part_NN of_IN the_DT ZF-MODELS_NNP project_NN ._.
        ‘ Each_DT of_IN our_PRP$ screens_NNS has_VBZ built_VBN on_IN the_DT previous_JJ one_CD by_IN including_VBG more_RBR specific_JJ assays_NNS’ ,_,
        explains_VBZ Dahm_NNP ._. Mutagenesis_NNP for_IN the_DT third_JJ screen_NN is_VBZ underway_NN ,_, but_CC the_DT assays_NNS ,_, which_WDT include_VBP
        looking_VBG for_IN defects_NNS that_WDT specifically_RB affect_VB adults_NNS ,_, are_VBP still_RB at_IN the_DT pilot_NN stage_NN ;_: this_DT
        autumn_NN ,_, the_DT project_NN 's_POS executive_NN committee_NN ,_, which_WDT is_VBZ headed_VBN by_IN Nüsslein-_NNP Volhard_NNP ,_, will_MD decide_VB
        which_WDT assays_NNS to_TO use_VB in_IN the_DT full-scale_JJ screen_NN ._. ‘ Just_RB over_IN half_PDT the_DT 17_CD partners_NNS in_IN the_DT
        consortium_NN will_MD come_VB to_TO Tübingen_NNP to_TO do_VB screens_NNS’ ,_, predicts_VBZ Dahm_NNP ._. ‘ By_IN bringing_VBG in_IN expertise_NN
        in_IN different_JJ systems_NNS in_IN this_DT way_NN we_PRP should_MD greatly_RB increase_VB the_DT efficiency_NN of_IN the_DT
        screen_NN’ ._.
      
      
        What_WP Else_RB Will_MD ZF-MODELS_NNP Do_VB ?_.
        The_DT ZF-MODELS_NNP consortium_NN ,_, which_WDT is_VBZ funded_VBN under_IN the_DT European_NNP Union_NNP 's_POS Sixth_NNP Framework_NNP
        Programme_NNP ,_, aims_VBZ to_TO establish_VB zebrafish_NN models_NNS for_IN human_JJ diseases_NNS ,_, discover_VB genes_NNS that_WDT will_MD
        lead_VB to_TO the_DT identification_NN of_IN new_JJ drug_NN targets_NNS ,_, and_CC gain_VB fundamental_JJ insights_NNS into_IN human_JJ
        development_NN ._. ‘ We_PRP will_MD mainly_RB focus_VB on_IN using_VBG advanced_VBN technologies_NNS that_WDT have_VBP recently_RB become_VB
        available_JJ’ ,_, says_VBZ scientific_JJ coordinator_NN Robert_NNP Geisler_NNP (_( Max_NNP Planck_NNP Institute_NNP for_IN
        Developmental_NNP Biology_NNP )_) ._. For_IN example_NN ,_, Geisler_NNP 's_POS lab_NN will_MD use_VB DNA_NNP chip_NN technology_NN to_TO
        investigate_VB gene_NN expression_NN patterns_NNS in_IN zebrafish_NN mutants_NNS and_CC so_RB provide_VB increased_VBN
        knowledge_NN of_IN the_DT regulatory_JJ pathways_NNS that_WDT act_NN in_IN zebrafish_NN development_NN ._.
        Consortium_NNP members_NNS will_MD also_RB use_VB ‘ reverse_VB genetics_NNS’ to_TO investigate_VB these_DT pathways_NNS ._. In_IN
        reverse_NN genetics_NNS ,_, researchers_NNS start_VBP with_IN a_DT gene_NN of_IN interest_NN and_CC investigate_VB the_DT phenotypic_JJ
        effect_NN of_IN altering_VBG its_PRP$ activity_NN ;_: by_IN contrast_NN ,_, in_IN ‘ forward_JJ genetics_NNS’ the_DT starting_NN point_NN is_VBZ
        to_TO look_VB for_IN a_DT particular_JJ phenotype_NN and_CC then_RB hunt_VB out_RP the_DT altered_VBN gene_NN that_WDT is_VBZ causing_VBG it_PRP ._.
        Two_CD reverse_VB genetics_NNS approaches_NNS will_MD be_VB used_VBN by_IN the_DT consortium_NN ._. Gene_NNP expression_NN will_MD be_VB
        transiently_RB knocked_VBN down_RB with_IN morpholinos_NNS ,_, short_JJ segments_NNS of_IN the_DT gene_NN that_WDT block_VBP its_PRP$
        function_NN ._. In_IN addition_NN ,_, a_DT recently_RB developed_VBN technique_NN known_VBN as_IN TILLING_NNP (_( targeting_VBG induced_VBN
        local_JJ lesions_NNS in_IN genomes_NNS )_) will_MD be_VB used_VBN to_TO knock_VB out_IN gene_NN activity_NN permanently_RB ._.
        The_DT first_JJ step_NN in_IN TILLING_NNP is_VBZ to_TO mutagenise_NN male_JJ zebrafish_NN and_CC mate_NN them_PRP with_IN untreated_JJ
        female_JJ fish_NN ,_, explains_VBZ Stemple_NNP ,_, whose_WP$ group_NN is_VBZ one_CD of_IN three_CD ZF-MODELS_NNP partners_NNS who_WP will_MD use_VB
        this_DT approach_NN ._. Offspring_NNP are_VBP raised_VBN to_TO adulthood_NN ,_, and_CC the_DT DNA_NNP of_IN each_DT individual_NN is_VBZ then_RB
        genotyped_JJ for_IN the_DT exon_NN of_IN interest_NN ._. The_DT consortium_NN already_RB has_VBZ a_DT collection_NN of_IN 6_CD ,_, 000_CD such_JJ
        individuals_NNS ,_, and_CC once_RB a_DT fish_NN carrying_VBG a_DT mutation_NN in_IN the_DT gene_NN of_IN interest_NN has_VBZ been_VBN
        identified_VBN ,_, it_PRP will_MD be_VB outcrossed_JJ to_TO produce_VB offspring_NN ,_, half_NN of_IN which_WDT will_MD carry_VB the_DT
        desired_VBN mutation_NN on_IN one_CD of_IN their_PRP$ chromosomes_NNS ._. ‘ It_PRP is_VBZ then_RB a_DT matter_NN of_IN identifying_VBG these_DT
        heterozygote_NN fish_NN and_CC incrossing_VBG them_PRP to_TO get_VB homozygous_JJ fish_NN in_IN which_WDT you_PRP can_MD see_VB the_DT
        phenotype_NN that_IN correlates_NNS with_IN that_DT mutation_NN’ ,_, says_VBZ Stemple_NNP ._.
        As_RB well_RB as_IN helping_VBG to_TO produce_VB knock-outs_JJ for_IN other_JJ researchers_NNS ,_, Stemple_NNP is_VBZ also_RB using_VBG
        the_DT TILLING_NNP technique_NN to_TO develop_VB zebrafish_NN models_NNS for_IN muscular_JJ dystrophy_NN ._. Among_IN the_DT genes_NNS
        that_WDT are_VBP important_JJ in_IN notochord_NN development_NN are_VBP those_DT that_IN encode_NN laminins_NNS ._. This_DT led_VBN
        Stemple_NNP into_IN studying_VBG muscular_JJ dystrophy_NN because_IN laminins_NNS are_VBP involved_VBN in_IN the_DT human_JJ
        disease_NN ._. ‘ When_WRB we_PRP used_VBD morpholinos_NNS to_TO disrupt_VB [_NN the_DT production_NN of_IN ]_NN dystroglycan_NN ,_, a_DT laminin_NN
        receptor_NN ,_, we_PRP got_VBD a_DT good_JJ model_NN for_IN muscular_JJ dystrophy_NN’ ,_, he_PRP explains_VBZ ._. Now_RB ,_, he_PRP plans_VBZ to_TO use_VB
        TILLING_NNP to_TO disrupt_VB up_IN to_TO 30_CD other_JJ genes_NNS known_VBN to_TO be_VB involved_VBN in_IN human_JJ muscular_JJ dystrophy_NN ._.
        ‘ In_IN particular_JJ ,_, we_PRP will_MD look_VB for_IN hypomorphic_JJ mutants_NNS ,_, fish_NN that_WDT are_VBP viable_JJ but_CC on_IN the_DT edge_NN
        of_IN falling_VBG apart_RB’ ._. These_DT mutants_NNS can_MD be_VB used_VBN to_TO identify_VB small_JJ molecules_NNS that_WDT push_VBP the_DT fish_NN
        into_IN muscular_JJ dystrophy_NN ._. Finding_VBG molecules_NNS that_WDT can_MD cause_VB a_DT disease_NN in_IN this_DT way_NN ‘ might_MD give_VB
        us_PRP a_DT handle_VB on_IN something_NN to_TO fix_VB the_DT disease_NN’ ,_, says_VBZ Stemple_NNP ._.
        In_IN another_DT strand_NN of_IN the_DT ZF-MODELS_NNP project_NN ,_, zebrafish_NN expressing_VBG green_JJ fluorescent_NN
        protein_NN (_( GFP_NNP )_) in_IN specific_JJ cells_NNS or_CC tissues_NNS will_MD be_VB generated_VBN and_CC characterised_JJ (_( Figure_NN 3_LS )_) ._.
        In_IN such_JJ fish_NN ,_, developing_VBG structures_NNS can_MD be_VB easily_RB imaged_JJ over_IN time_NN in_IN the_DT living_VBG embryo_NN ._.
        One_CD researcher_NN working_VBG on_IN this_DT aspect_NN of_IN the_DT project_NN is_VBZ Stephen_NNP Wilson_NNP ,_, Professor_NNP of_IN
        Developmental_NNP Genetics_NNP at_IN University_NNP College_NNP London_NNP (_( United_NNP Kingdom_NNP )_) ._. GFP_NNP lines_NNS can_MD be_VB made_VBN
        either_CC by_IN attaching_VBG to_TO the_DT GFP_NNP gene_NN regions_NNS of_IN DNA_NNP that_DT control_NN ,_, or_CC ‘ drive_NN’ ,_, GFP_NNP expression_NN
        in_IN selected_VBN cell_NN types_NNS or_CC by_IN allowing_VBG the_DT GFP_NNP gene_NN to_TO insert_VB randomly_RB in_IN the_DT genome_NN and_CC
        looking_VBG for_IN fish_NN with_IN specific_JJ expression_NN patterns_NNS ._. ‘ There_EX are_VBP now_RB many_JJ lines_NNS of_IN fish_NN
        available_JJ with_IN different_JJ GFP_NNP expression_NN patterns_NNS’ ,_, says_VBZ Wilson_NNP ,_, ‘ and_CC it_PRP is_VBZ important_JJ to_TO
        catalogue_NN their_PRP$ expression_NN so_IN that_IN people_NNS can_MD use_VB the_DT most_RBS appropriate_JJ lines_NNS for_IN their_PRP$
        research_NN’ ._.
        Wilson_NNP 's_POS own_JJ interest_NN is_VBZ in_IN neuroanatomy_NN ._. Together_RB with_IN Jon_NNP Clarke_NNP ,_, another_DT
        developmental_NN neurobiology_NN group_NN leader_NN at_IN University_NNP College_NNP London_NNP ,_, he_PRP plans_VBZ to_TO analyse_NN
        GFP_NNP lines_NNS in_IN which_WDT small_JJ groups_NNS of_IN neurons_NNS or_CC particular_JJ parts_NNS of_IN neurons_NNS are_VBP labelled_JJ ,_, and_CC
        in_IN this_DT way_NN start_NN to_TO build_VB a_DT detailed_VBN reconstruction_NN of_IN early_JJ brain_NN neuroanatomy_NN ._. This_DT ,_, in_IN
        combination_NN with_IN other_JJ work_NN on_IN zebrafish_NN carrying_VBG mutations_NNS affecting_VBG neural_NN development_NN ,_,
        will_MD give_VB the_DT team_NN ‘ a_DT better_JJR picture_NN of_IN how_WRB a_DT vertebrate_NN brain_NN is_VBZ built_VBN’ ._.
        A_DT final_JJ ,_, important_JJ aspect_NN of_IN the_DT ZF-MODELS_NNP project_NN ,_, adds_VBZ Dahm_NNP ,_, is_VBZ database_NN construction_NN ._.
        ‘ We_PRP will_MD be_VB developing_VBG a_DT set_NN of_IN databases_NNS that_WDT will_MD integrate_VB all_DT of_IN the_DT project_NN data_NN’ ,_, he_PRP
        explains_VBZ ._. ‘ In_IN addition_NN ,_, we_PRP hope_VBP to_TO integrate_VB our_PRP$ data_NNS with_IN that_DT of_IN ZFIN_NNP in_IN the_DT United_NNP
        States_NNPS to_TO make_VB one_CD central_JJ zebrafish_NN resource_NN’ ._.
      
      
        But_CC Fish_NN Are_VBP n't_RB People_NNS
        The_DT researchers_NNS of_IN the_DT ZF-MODELS_NNP consortium_NN are_VBP understandably_RB excited_VBN about_IN
        participating_VBG in_IN what_WP will_MD ,_, says_VBZ Geisler_NNP ,_, bring_VBP an_DT already_RB strong_JJ European_JJ zebrafish_NN
        community_NN closer_RBR together_RB ._. But_CC zebrafish_NN researchers_NNS in_IN the_DT United_NNP States_NNPS are_VBP also_RB excited_VBN
        by_IN the_DT ZF-MODELS_NNP project_NN ._. ‘ We_PRP need_VBP big_JJ lab_NN models_NNS like_IN ZF-MODELS_NNP in_IN developmental_NN biology_NN’ ,_,
        says_VBZ Hopkins_NNP ,_, noting_VBG that_IN the_DT days_NNS of_IN small_JJ groups_NNS working_VBG in_IN isolation_NN are_VBP long_RB gone_VBN ._. This_DT
        consortium_NN ,_, adds_VBZ Howard_NNP Hughes_NNP Medical_NNP Institute_NNP Investigator_NNP Leonard_NNP Zon_NNP (_( Harvard_NNP Medical_NNP
        School_NNP ,_, Boston_NNP ,_, Massachusetts_NNP ,_, United_NNP States_NNPS )_) ,_, ‘ will_MD not_RB only_RB have_VB an_DT effect_NN on_IN European_JJ
        zebrafish_NN science_NN but_CC also_RB on_IN how_WRB it_PRP is_VBZ done_VBN in_IN the_DT United_NNP States_NNPS’ ._.
        But_CC how_WRB much_JJ can_MD zebrafish_NN tell_VB us_PRP about_IN human_JJ development_NN and_CC disease_NN ?_. A_DT lot_NN ,_, say_VBP
        zebrafish_NN researchers_NNS ._. ‘ Fish_NN really_RB are_VBP just_RB little_JJ people_NNS with_IN fins_NNS’ ,_, says_VBZ Hopkins_NNP ._. ‘ Of_IN
        course_NN ,_, there_EX are_VBP developmental_NN differences_NNS between_IN people_NNS and_CC fish_NN ,_, and_CC no_DT one_CD pretends_NNS
        that_IN we_PRP can_MD answer_VB every_DT question_NN about_IN human_JJ development_NN in_IN zebrafish_NN’ ._. Nevertheless_RB ,_,
        zebrafish_NN studies_NNS can_MD provide_VB valuable_JJ clues_NNS to_TO the_DT genes_NNS involved_VBN in_IN human_JJ diseases_NNS and_CC to_TO
        potential_JJ targets_NNS for_IN therapeutic_JJ interventions_NNS ._. Hopkins_NNP provides_VBZ the_DT following_JJ
        illustration_NN :_: ‘ We_PRP have_VBP been_VBN doing_VBG “ shelf_NN screens_NNS” ,_, in_IN which_WDT we_PRP go_VBP back_RB to_TO our_PRP$ collection_NN of_IN
        mutants_NNS to_TO find_VB all_DT those_DT that_WDT affect_VBP the_DT development_NN of_IN a_DT single_JJ organ_NN ._. When_WRB Zhaoxia_NNP Sun_NNP ,_,
        a_DT postdoc_NN in_IN my_PRP$ lab_NN who_WP now_RB has_VBZ an_DT independent_JJ position_NN at_IN Yale_NNP Medical_NNP School_NNP ,_, screened_VBD
        three-day-old_JJ fish_NN for_IN cystic_JJ kidney_NN disease_NN ,_, she_PRP found_VBD 12_CD different_JJ genes_NNS ._. Two_CD were_VBD known_VBN
        to_TO cause_VB human_JJ cystic_JJ kidney_NN disease_NN ,_, so_IN we_PRP knew_VBD we_PRP were_VBD in_IN the_DT human_JJ disease_NN pathway_NN
        somewhere_RB ,_, but_CC we_PRP had_VBD no_DT idea_NN what_WP the_DT other_JJ genes_NNS were_VBD’ ._. Hopkins_NNP and_CC Sun_NNP have_VBP since_IN
        identified_VBN the_DT remaining_VBG genes_NNS ,_, and_CC these_DT point_NN to_TO a_DT single_JJ pathway_NN being_VBG involved_VBN in_IN the_DT
        human_JJ disease_NN ._.
        Developmental_NNP geneticist_NN Didier_NNP Stainier_NNP (_( University_NNP of_IN California_NNP ,_, San_NNP Francisco_NNP ,_,
        California_NNP ,_, United_NNP States_NNPS )_) is_VBZ also_RB using_VBG zebrafish_NN to_TO study_VB organ_NN development_NN ,_, in_IN
        particular_JJ ,_, heart_NN development_NN ._. The_DT zebrafish_NN heart_NN is_VBZ like_IN the_DT early_JJ human_JJ heart—a_NN tube_NN
        with_IN an_DT atrium_NN ,_, ventricle_NN ,_, and_CC valves_NNS ._. ‘ Everything_NN we_PRP have_VBP found_VBN in_IN the_DT fish_NN is_VBZ relevant_JJ to_TO
        the_DT human_JJ heart_NN’ ,_, says_VBZ Stainier_NNP ._. ‘ Obviously_RB ,_, there_EX are_VBP additional_JJ processes_VBZ involved_VBN in_IN
        humans_NNS ,_, but_CC the_DT basic_JJ outline_NN of_IN heart_NN development_NN in_IN fish_NN and_CC people_NNS is_VBZ largely_RB similar_JJ’ ._.
        Stainier_NNP has_VBZ a_DT collection_NN of_IN zebrafish_NN in_IN which_WDT valve_NN formation_NN is_VBZ faulty_JJ ._. ‘ Some_DT of_IN the_DT
        genes_NNS we_PRP have_VBP found_VBN will_MD be_VB involved_VBN in_IN human_JJ congenital_NN valve_NN defects_NNS’ ,_, he_PRP predicts_VBZ ._.
        Knowing_VBG the_DT identity_NN of_IN these_DT genes_NNS will_MD be_VB useful_JJ diagnostically_RB ,_, but_CC ,_, in_IN addition_NN ,_,
        zebrafish_NN studies_NNS can_MD reveal_VB exactly_RB what_WP has_VBZ gone_VBN wrong_JJ at_IN a_DT cellular_JJ level_NN ._. The_DT ability_NN
        to_TO follow_VB individual_JJ cells_NNS as_IN organs_NNS develop_VBP is_VBZ key_JJ to_TO this_DT ,_, says_VBZ Stainier_NNP ,_, who_WP reported_VBD in_IN
        March_NNP that_DT fibronectin_NN is_VBZ required_VBN for_IN heart_NN development_NN because_IN ,_, by_IN regulating_VBG the_DT
        polarisation_NN of_IN epithelial_NN cells_NNS ,_, fibronectin_NN ensures_VBZ the_DT correct_JJ migration_NN of_IN myocardial_NN
        cells_NNS ._. And_CC in_IN this_DT issue_NN of_IN PLoS_NNP Biology_NNP ,_, Stainier_NNP 's_POS lab_NN have_VBP identified_VBN another_DT zebrafish_NN
        gene_NN that_WDT is_VBZ involved_VBN in_IN heart_NN development—cardiofunk_NN ,_, which_WDT encodes_NNS a_DT special_JJ type_NN of_IN
        muscle_NN protein_NN ._.
      
      
        A_DT Proliferation_NNP of_IN Zebrafish_NNP Models_NNP of_IN Human_NNP Disease_NNP
        Many_JJ researchers_NNS are_VBP now_RB recognising_VBG the_DT value_NN of_IN zebrafish_NN models_NNS of_IN human_JJ disease_NN ._.
        Over_IN the_DT past_JJ three_CD to_TO four_CD years_NNS ,_, says_VBZ Zon_NNP ,_, this_DT area_NN of_IN research_NN has_VBZ become_VBN a_DT growth_NN
        industry_NN ._. The_DT interest_NN in_IN disease_NN models_NNS has_VBZ grown_VBN hand-in-hand_JJ with_IN the_DT development_NN of_IN
        morpholinos_NNS to_TO knock_VB out_IN specific_JJ genes_NNS ,_, and_CC the_DT advent_NN of_IN TILLING_NNP ,_, says_VBZ Zon_NNP ,_, ‘ has_VBZ set_VBN off_IN
        a_DT whole_JJ new_JJ fury_NN ._. There_EX are_VBP now_RB large_JJ numbers_NNS of_IN investigators_NNS who_WP will_MD try_VB to_TO knock_VB out_RP
        their_PRP$ favourite_NN gene_NN and_CC come_VB up_RB with_IN a_DT model_NN’ ._.
        Zon_NNP has_VBZ worked_VBN on_IN disease_NN models_NNS for_IN blood_NN (_( Figure_NN 4_LS )_) ,_, blood_NN vessel_NN ,_, and_CC heart_NN disorders_NNS
        but_CC is_VBZ currently_RB studying_VBG zebrafish_NN models_NNS of_IN cancer_NN ._. ‘ We_PRP started_VBD by_IN doing_VBG chemical_NN
        mutagenesis_NNS and_CC screened_VBD for_IN cell-cycle_JJ mutants_NNS ._. These_DT were_VBD embryonic_JJ lethals_NNS ,_, but_CC when_WRB we_PRP
        looked_VBD at_IN heterozygote_NN carriers_NNS of_IN these_DT mutations_NNS ,_, some_DT developed_VBN cancer_NN at_IN a_DT high_JJ rate_NN as_IN
        adults_NNS’ ._. Now_RB Zon_NNP and_CC his_PRP$ colleagues_NNS have_VBP returned_VBN to_TO the_DT cell-cycle_JJ mutant_JJ that_WDT yielded_VBD
        this_DT cancer-susceptible_JJ heterozygote_NN and_CC are_VBP using_VBG embryos_NNS in_IN high-throughput_JJ screening_NN
        assays_NNS to_TO look_VB for_IN small_JJ molecules_NNS that_WDT can_MD suppress_VB the_DT cell-cycle_JJ phenotype_NN ._. These_DT
        molecules_NNS ,_, reasons_NNS Zon_NNP ,_, may_MD have_VB potential_JJ as_IN anticancer_NN drugs_NNS ._.
      
      
        And_CC the_DT Future_NNP of_IN Zebrafish_NNP Research_NNP ?_.
        Bigger_JJR and_CC bigger_JJR seems_VBZ to_TO be_VB the_DT consensus_NN ._. Chemical_NN screens_NNS like_IN Zon_NNP 's_POS for_IN anticancer_NN
        drugs_NNS can_MD be_VB set_VBN up_RP for_IN other_JJ human_JJ diseases_NNS such_JJ as_IN muscular_JJ dystrophy_NN ._. Work_NN like_IN
        Stainier_NNP 's_POS on_IN organ_NN development_NN may_MD have_VB applications_NNS in_IN tissue_NN engineering_NN ._. ‘ If_IN we_PRP can_MD
        find_VB out_IN what_WP drives_NNS differentiation_NN in_IN zebrafish_NN’ ,_, he_PRP suggests_VBZ ,_, ‘ we_PRP might_MD be_VB able_JJ to_TO do_VB
        the_DT same_JJ for_IN human_JJ cells_NNS’ ,_, making_VBG human_JJ tissue_NN replacement_NN therapy_NN a_DT practical_JJ possibility_NN ._.
        And_CC while_IN many_JJ zebrafish_NN researchers_NNS will_MD continue_VB to_TO study_VB development_NN ,_, others_NNS are_VBP now_RB
        moving_VBG into_IN the_DT realms_NNS of_IN physiology_NN and_CC behavioural_NN studies_NNS ._.
        Geisler_NNP sums_NNS up_RB zebrafish_NN developmental_NN research_NN past_JJ ,_, present_JJ ,_, and_CC future_NN as_IN follows_VBZ :_:
        ‘ No_DT other_JJ [_NN vertebrate_NN ]_NN organism_NN offers_VBZ the_DT same_JJ combination_NN of_IN transparent_JJ and_CC accessible_JJ
        embryos_NNS ,_, cost-effective_JJ mutagenesis_NNS screening_NN ,_, and_CC ,_, more_RBR recently_RB ,_, a_DT sequenced_JJ genome_NN ,_,
        [_NN DNA_NNP ]_NN chip_NN ,_, GFP_NNP ,_, and_CC knockout_NN technology_NN’ ._. Add_VB to_TO that_DT the_DT potential_NN of_IN zebrafish_NN embryos_NNS
        as_IN a_DT screening_NN platform_NN for_IN small_JJ molecule_NN libraries_NNS and_CC the_DT new_JJ technologies_NNS that_WDT allow_VBP
        forward_RB and_CC reverse_VB genetics_NNS ,_, and_CC it_PRP is_VBZ clear_JJ that_DT zebrafish_NN are_VBP not_RB about_IN to_TO revert_NN to_TO
        being_VBG pretty_RB pets_NNS swimming_VBG in_IN small_JJ tanks_NNS in_IN the_DT corner_NN of_IN the_DT living_VBG room_NN ._.
      
      
        Where_WRB to_TO Find_VBP Out_IN More_JJR
        ZF-MODELS_NNP
        More_JJR details_NNS of_IN the_DT work_NN included_VBN in_IN this_DT European_NNP Union_NNP Integrated_NNP Project_NNP can_MD be_VB found_VBN
        at_IN http_NN :_: /_NN /_NN www_NN ._. zf-models_JJ ._. org_NN
        ZFIN_NNP
        The_DT ZFIN_NNP Web_NNP site_NN ,_, at_IN http_NN :_: /_NN /_NN z_SYM ._. n_NN ._. org_NN /_NN ZFIN_NNP ,_, provides_VBZ an_DT extensive_JJ database_NN for_IN the_DT
        zebrafish_NN community_NN including_VBG genetic_JJ ,_, genomic_JJ ,_, and_CC developmental_NN information_NN ;_: search_NN
        engines_NNS for_IN zebrafish_NN researchers_NNS and_CC laboratories_NNS ;_: listings_NNS of_IN meetings_NNS ;_: and_CC links_NNS to_TO many_JJ
        other_JJ zebrafish_NN sites_NNS ,_, including_VBG sites_NNS with_IN movies_NNS of_IN zebrafish_NN development_NN ._.
        The_DT special_JJ issue_NN of_IN 
        Development_NNP (_( Dec_NNP 1_CD ;_: 1996_CD ;_: 123_CD :_: 1_CD –_NN 461_CD )_) on_IN the_DT first_JJ two_CD mutagenesis_NNS
        screens_NNS contains_VBZ 37_CD research_NN articles_NNS and_CC can_MD be_VB freely_RB accessed_JJ at_IN
        http_NN :_: /_NN /_NN dev_NN ._. biologists_NNS ._. org_NN /_NN content_NN /_NN vol_NN 123_CD /_NN issue_NN 1_CD /_NN index_NN ._. shtml_NN
      
    
  
